NMN vs NR vs Niacin — NAD+ Precursor Comparison
All three raise NAD+ levels but through different pathways, at vastly different costs, and with different side effect profiles. A 2026 head-to-head human clinical trial in Nature Metabolism found NMN and NR comparable in raising blood NAD+, while nicotinamide (NAM) produced only a transient effect. Here's how all three compare.
| NMN | NR | Niacin | |
|---|---|---|---|
| Pathway to NAD+ | NMNAT enzymes (may convert to NR first) | NRK pathway — enters cells directly, converts to NMN then NAD+ | Preiss-Handler pathway — 3-step process |
| Efficacy (Human Data) | Significantly raises whole-blood NAD+ | Significantly raises whole-blood NAD+ | Raises NAD+ — some n=1 data suggests comparable potency per mg |
| Head-to-Head | NMN and NR comparable — 2026 Nature Metabolism RCT (n=65) | NMN and NR comparable — same trial | NAM (nicotinamide) only transient effect in same trial |
| Flush | None | None | Yes — “niacin flush” common at effective doses |
| Cholesterol Effects | Not demonstrated | Not demonstrated | Raises HDL, lowers LDL/triglycerides — FDA-approved for dyslipidemia |
| Cellular Entry | Debated — may require conversion to NR first | Direct cellular entry via transporters | Indirect — multiple conversion steps |
| Human Trial Volume | 20+ clinical studies | 40+ clinical studies — more established | Decades of data as supplement and medication |
| Regulatory Status | FDA reviewing as potential drug ingredient | GRAS status — well-established supplement | Long-established supplement and medication |
| Cost | $50–150/month | $30–80/month | $5–15/month |
| Best For | Those prioritizing convenience, no flush | Best-studied NAD+ precursor, no flush | Budget-conscious, also want cholesterol benefits |
Bottom Line
NR has the strongest human trial base and is generally considered the best-studied option. NMN is comparable in efficacy but costs more and has a more uncertain regulatory future. Niacin raises NAD+ at ~1% of the cost but causes flushing and has different downstream effects. All three effectively raise NAD+ — the choice comes down to budget, flush tolerance, and secondary goals.
For educational and research purposes only. Not medical advice.